Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice

Diabetes

Volumn 59, Issue 10, 2010, Pages 2540-2548

  Bindom, Sharell M ^a   Hans, Chetan P ^a   Xia, Huijing ^a   Boulares, A Hamid ^a   Lazartigues, Eric ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; DIET RESTRICTION; GENE THERAPY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HYPERGLYCEMIA; INSULIN SENSITIVITY; MALE; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS; PANCREAS INSUFFICIENCY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RECEPTOR BLOCKING; VIRUS EXPRESSION;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; CELL DIVISION; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE THERAPY; GENES, REPORTER; GLUCOSE TOLERANCE TEST; GREEN FLUORESCENT PROTEINS; HOMEOSTASIS; HUMANS; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, TRANSGENIC; OBESITY; PANCREAS; PEPTIDYL-DIPEPTIDASE A;

EID: 77957558776     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db09-0782     Document Type: Article

References (50)

1. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006;86:747-803
2. Chappell M, Millsted A, Diz D, Brosnihan K, Ferrario CM. Evidence for an intrinsic angiotensin system in the canine pancreas. J hypertens 1991;9: 751-759
3. Lau T, Carlsson PO, Leung PS. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 2004;47: 240-248
4. Tahmasebi M, Puddefoot JR, Inwang ER, Vinson GP. The tissue reninangiotensin system in human pancreas. J Endocrinol 1999;161:317-322
5. Carlsson PO, Berne C, Jansson L. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 1998;41:127-133
6. Ko S-H, Kwon H-S, Kim S-R, Moon S-D, Ahn Y-B, Song K-H, Son H-S, Cha B-Y, Lee K-W, Son H-Y, Kang S-K, Park C-G, Lee I-K, Yoon K-H. Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats. Biochem Biophys Res Commun 2004;316:114-122
7. Lupi R, Guerra SD, Bugliani M, Boggi U, Mosca F, Torri S, Prato SD, Marchetti P. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur J Endocrinol 2006;154:355-361
8. Nakayama M, Inoguchi T, Sonta T, Maeda Y, Sasaki S, Sawada F, Tsubouchi H, Sonoda N, Kobayashi K, Sumimoto H, Nawata H. Increased expression of NAD(P)H oxidase in islets of animal models of type 2 diabetes and its improvement by an AT1 receptor antagonist. Biochem Biophys Res Commun 2005;332:927-933
9. 2-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 2006;55:367-374
10. Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME. Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat. Diabetes 2004;53:989-997
11. Bindom S, Lazartigues E. The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol 2009;302:193-202
12. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000;87:e1-e9
13. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000;275: 33238-33243
14. Santos RAS, Silva ACS, Maric C, Silva DMR, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SVB, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss H-P, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 2003;100:8258-8263
15. Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, Smith AI, Shaw T, Warner FJ, Zuilli A, Burrell LM, Angus PW. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005;54:1790-1796
16. Santos RAS, Campagnole-Santos M. Central and peripheral actions of angiotensin-(1-7). Braz J Med Biol Res 1994;27:1033-1047
17. Almeida AP, Frábregas BC, Madureira MM, Santos RJS, Campagnole- Santos MJ, Santos RAS. Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart. Braz J Med Biol Res 2000;33:709-713
18. Niu MJ, Yang JK, Lin SS, Ji XJ, Guo LM. Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice. Endocrine 2008;34:56-61
19. Gerich JE. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes 2002;51:S117-S121
20. Santos SHS, Fernandes LR, Mario EG, Ferreira AVM, Porto LCJ, Alvarez- Leite JI, Botion LM, Bader M, Alenina N, Santos RAS. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 2008;57:340-347
21. Feng Y, Yue X, Xia H, Bindom SM, Hickman P, Filipeanu C, Wu G, Lazartigues E. ACE2 over-expression in the subfornical organ prevents the angiotensin-II-mediated pressor and drinking responses and is associated with AT1 receptor down-regulation. Circ Res 2008;102:628-629
22. Ye M, Wysocki J, Naaz P, Salabat MR, LaPointe MS, Batlle D. Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension 2004;43:1120-1125
23. Tikellis C, Johnston CI, Forbes JM, Burns WC, Burrell LM, Risvanis J, Cooper ME. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003;41:392-397
24. Coleman D. Diabetes-obesity syndromes in mice. Diabetes 1982;32:1-6
25. Stone D, David A, Bolognani F, Lowenstein PR, Castro MG. Viral vectors for gene delivery and gene therapy within the endocrine system. J Endocrinol 2000;164:103-118
26. Leibowitz G, Beattie GM, Kafri T, Cirulli V, Lopez AD, Hayek A, Levine F. Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 1999;48:745-753
27. Raper S, DeMatteo R. Adenovirus-mediated in vivo gene transfer and expression in normal rat pancreas. Pancreas 1996;12:401-410
28. McClane SJ, Hamilton TE, Burke CV, Raper SE. Functional cnsequences of adenovirus-mediated murine pancreatic gene transfer. Human Gene Ther 1997;8:739-746
29. Sinnayah P, Lindley TE, Staber PD, Cassell MD, Davidson BL, Davisson RL. Selective gene transfer to key cardiovascular regions of the brain: comparison of two viral vector systems. Hypertension 2002;39:603-608
30. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Pettiti M, Natali A, Mari A, DeFronzo RA. Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 2003;46:1211-1219
31. Giani JF, Mayer MA, Munoz MC, Silberman EA, Hocht C, Taira CA, Gironacci MM, Turyn D, Dominici FP. Chronic infusion of angiotensin- (1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am J Physiol Endocrinol Metab 2009;296:E262-E271
32. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A. β-Cell adaptation and decompensation during the progression of diabetes. Diabetes 2001;50:S154-S159
33. 2-(1H-tetrazol-5- yl)-[1,1′]-biphenyl]- 4-yl]methyl]-L-valine] enhances pancreatic islet morphology and function in a mouse model of type 2 diabetes. J Pharmacol Exp Ther 2008;327:683-691
34. Menon J, Soto-Pantoja DR, Callahan MF, Cline JM, Ferrario CM, Tallant EA, Gallagher PE. Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase- 2. Cancer Res 2007;67:2809-2815
35. Tallant EA, Ferrario CM, Gallagher PE. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am J Physiol Heart Circ Physiol 2005;289:H1560-H1566
36. Zimpelmann J, Burns KD. Angiotensin-(1-7) activates growth stimulatory pathways in human mesangial cells. Am J Physiol Renal Physiol 2009;296: F337-346
37. Ferrario CM, Smith RD, Brosnihan B, Chappell MC, Campese VM, Vesterqvist O, Liao WC, Ruddy MC, Grim CE. Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension[ast]. Am J Hypertens 2002;15:557-564
38. Heringer-Walther S, Batista EN, Walther T, Khosla MC, Santos RAS, Campagnole-Santos MJ. Baroreflex improvement in SHR after ACE inhibition involves angiotensin-(1-7). Hypertension 2001;37:1309-1314
39. Zhang H, Wada J, Hida K, Tsuchiyama Y, Hiragushi K, Shikata K, Wang H, Lin S, Kanwar YS, Makino H. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J Biol Chem 2001;276:17132-17139
40. Fukui K, Yang Q, Cao Y, Takahashi N, Hatakeyama H, Wang H, Wada J, Zhang Y, Marselli L, Nammo T, Yoneda K, Onishi M, Higashiyama S, Matsuzawa Y, Gonzalez FJ, Weir GC, Kasai H, Shimomura I, Miyagawa JI, Wollheim CB, Yamagata K. The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metabolism 2005;2:373-384
41. Akpinar P, Kuwajima S, Krutzfeldt J, Stoffel M. Tmem27. A cleaved and shed plasma membrane protein that stimulates pancreatic beta cell proliferation. Cell Metabolism 2005;2:385-397
42. Dias-Peixoto MF, Santos RAS, Gomes ERM, Alves MNM, Almeida PWM, Greco L, Rosa M, Fauler B, Bader M, Alenina N, Guatimosim S. Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes. Hypertension 2008;52:542-548
43. Chandrashekhar Y, Anway R, Godavarthy A, Shekels L. LVAD therapy up-regulates ACE-2 but may decrease apoptosis and mediate reverse remodeling via a "non ang 1-7 non mas receptor" pathway in patients with end stage heart failure (Abstract). Circulation 2007;116:II-454
44. 2-cell function in young type 2 diabetic mice. Antioxid Redox Signal 2007;9:869-878
45. Yin H, Chao J, Bader M, Chao L. Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling. Peptides 2007;28:1383-1389
46. Pavlovic D, Andersen N, Mandrup-Poulsen T, Eizirik D. Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokineinduced apoptosis in purified rat pancreatic beta-cells. Eur Cytokine Netw 2000;11:267-274
47. Srinivasan S, Bernal-Mizrachi E, Ohsugi M, Permutt MA. Glucose promotes pancreatic islet beta-cell survival through a PI 3-kinase/Akt-signaling pathway. Am J Physiol Endocrinol Metab 2002;283:E784-E793
48. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006;116:1802-1812
49. Kahn SE. The importance of {beta}-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001;86:4047-4058
50. Finegood DT, McArthur MD, Kojwang D, Thomas MJ, Topp BG, Leonard T, Buckingham RE. β-Cell mass dynamics in Zucker diabetic fatty rats: rosiglitazone prevents the rise in net cell death. Diabetes 2001;50:1021-1029